Skip to content

Drug interactions

Imatinib + Talazoparib

Severity: Moderate

Imatinib and Talazoparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib may inhibit BCRP and thereby increase talazoparib exposure. This may increase hematologic toxicity such as anemia, neutropenia and thrombocytopenia.

What this interaction means in plain words

Imatinib and Talazoparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Talazoparib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of BCRP-mediated efflux of talazoparib increases its systemic exposure.

What to do

Monitor blood counts closely during coadministration and reduce the talazoparib dose or interrupt it if toxicity occurs. Consider an alternative to imatinib where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Talazoparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Talazoparib?

MediHelp rates the interaction as moderate. Imatinib and Talazoparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib may inhibit BCRP and thereby increase talazoparib exposure. This may increase hematologic toxicity such as anemia, neutropenia and thrombocytopenia.

How serious is the interaction between Imatinib and Talazoparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts closely during coadministration and reduce the talazoparib dose or interrupt it if toxicity occurs. Consider an alternative to imatinib where possible.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in